#Canada #MedTech #Calgary #EMeRG #Hospital Intel Suite

EMeRG Launches Hospital Intel Suite™

A Leap Forward in MedTech Intelligence
CALGARY, AB, July 22, 2026 - Recognizing a significant gap in hospital intelligence, EMeRG has introduced the Hospital Intel Suite™, an innovative SaaS platform designed to enhance the visibility of hospitals globally. This cutting-edge tool harnesses the power of AI and predictive analytics to transform how medical technology companies gather and utilize hospital data.

The need for unified hospital intelligence is paramount, especially as commercial teams often struggle to access comprehensive insights into hospital capabilities and technology adoption. EMeRG's solution addresses this pain point by consolidating hospital infrastructure, clinical capabilities, and a multitude of intelligence factors into a single, user-friendly platform.

Background and Development

The Hospital Intel Suite™ is the result of nearly seven years of rigorous research conducted across over 65 countries. This platform evolved from EMeRG's earlier tool, HospeTrack, which was launched in 2018. Initially designed to aid medical technology companies in strategizing their market approaches, the suite has since expanded its functionalities to encompass market sizing, installed base analytics, opportunity mapping, and overall market analytics.

By integrating advanced predictive analytics, the platform can forecast future demand and identify capital replacement cycles, thereby offering unprecedented insights into over 130,000 hospitals and more than 200 medical device and health technology categories.

Applications and Benefits

The primary users of the Hospital Intel Suite™ are medical technology companies, but its capabilities extend to investors, consulting firms, and other healthcare innovators. This platform allows organizations to assess market conditions, discover growth opportunities, and facilitate data-driven strategic decisions.

Krishanu Bhattacharjee, Founder and CEO of EMeRG, emphasizes that the real challenge in MedTech isn’t merely market intelligence but hospital intelligence. “Our vision for the Hospital Intel Suite is to provide healthcare innovators with a clearer understanding of each hospital, ensuring that life-saving technologies reach patients guided by insight rather than speculation,” he stated.

The platform draws on data meticulously curated by a team of biomedical engineers, MedTech analysts, and data scientists, enhancing its reliability and efficacy.

Supporting Innovation

In addition to established medical technology enterprises, the Hospital Intel Suite™ is a valuable resource for startups, universities, incubators, and innovation ecosystems. It aids in validating market potentials, pinpointing pilot hospitals for testing, and accelerating the commercialization process for new technologies.

“We aim to simplify commercial intelligence,” explained Tanuja Khanolkar, COO of EMeRG. “The Hospital Intel Suite empowers organizations to effectively size their markets, understand existing installations, and identify replacement opportunities, all through one comprehensive intelligence platform.”

Global Availability and Future Expansion

The Hospital Intel Suite™ is now accessible worldwide, with plans for continuous expansion to cover more hospitals, enhance predictive intelligence features, include additional medical technology categories, and develop AI-driven decision support tools.

About EMeRG

Based in Calgary, EMeRG is a leading global research and advisory firm in the MedTech sector, assisting top medical technology organizations through proprietary research and advanced analytics. With their innovative Hospital Intel Suite™, EMeRG is dedicated to helping clients seize opportunities, validate markets, and accelerate their path to commercial success.

For further details, you can visit www.hospitalintel.com or www.emerg-inc.com.